The HCPLive Infectious Disease condition center page is a comprehensive resource for clinical news and insights on respiratory health. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for asthma, COPD, interstitial lung disease, COVID-19, and more.
October 16th 2024
Patients who underwent FESS required less medication and had fewer allergy and pulmonology visits than patients who did not have surgery.
Clinical Comparison of Rituximab and Cyclophosphamide for Interstitial Lung Disease (ILD-CTD)
November 28th 2022Despite its frequent use as a rescue therapy for patients with interstitial lung disease associated with connective tissue disorder, the effectiveness of rituximab hasn't been evaluated in many clinical trials.
Why Interstitial Lung Disease Diagnosis is Often Delayed
October 4th 2022"Especially when untreated and in late stages of progression, ILD is well known to impact health related quality of life," according to Dr. Briana DiSilvio. "Chronic dyspnea, cough, and reduced exercise capacity can become disabling."
Promising Data from InPedILD Phase 3 Trial Revealed at ERS Congress 2022
September 8th 2022Novel insights into the risk-benefit profile of nintedanib in children and adolescents with fibrosing interstitial lung disease (ILD) were provided by late-breaking data presented at ERS 2022 regarding the InPedILD clinical trial.
Pharmacy-Supported Digital Medicine Program Improves Asthma Control
September 8th 2022Late-breaking data presented at ERS Congress 2022 show that inhaler sensors and mobile health (mHealth) applications combined with pharmacist counseling improved treatment adherence for patients with uncontrolled asthma.